Subclinical hyperthyroidism and the risk of coronary heart disease and mortality

Tinh Hai Collet, Jacobijn Gussekloo, Douglas C. Bauer, Wendy P J Den Elzen, Anne R. Cappola, Philippe Balmer, Giorgio Iervasi, Bjørn O. Åsvold, José A. Sgarbi, Henry Völzke, Bariş Gencer, Rui M B Maciel, Sabrina Molinaro, Alexandra Bremner, Robert N. Luben, Patrick Maisonneuve, Jacques Cornuz, Anne B. Newman, Kay Tee Khaw, Rudi G J WestendorpJayne A. Franklyn, Eric Vittinghoff, John P. Walsh, Nicolas Rodondi

Research output: Contribution to journalArticlepeer-review


Background: Data from prospective cohort studies regarding the association between subclinical hyperthyroidism and cardiovascular outcomes are conflicting.Weaimed to assess the risks of total and coronary heart disease (CHD) mortality, CHD events, and atrial fibrillation (AF) associated with endogenous subclinical hyperthyroidism among all available large prospective cohorts. Methods: Individual data on 52 674 participants were pooled from 10 cohorts. Coronary heart disease events were analyzed in 22 437 participants from 6 cohorts with available data, and incident AF was analyzed in 8711 participants from 5 cohorts. Euthyroidism was defined as thyrotropin level between 0.45 and 4.49 mIU/L and endogenous subclinical hyperthyroidism as thyrotropin level lower than 0.45 mIU/L with normal free thyroxine levels, after excluding those receiving thyroid-altering medications. Results: Of 52 674 participants, 2188 (4.2%) had subclinical hyperthyroidism. During follow-up, 8527 participants died (including 1896 from CHD), 3653 of 22 437 had CHD events, and 785 of 8711 developed AF. In ageand sex-adjusted analyses, subclinical hyperthyroidism was associated with increased total mortality (hazard ratio [HR], 1.24, 95% CI, 1.06-1.46), CHD mortality (HR, 1.29; 95% CI, 1.02-1.62), CHD events (HR, 1.21; 95% CI, 0.99-1.46), and AF (HR, 1.68; 95% CI, 1.16-2.43). Risks did not differ significantly by age, sex, or preexisting cardiovascular disease and were similar after further adjustment for cardiovascular risk factors, with attributable risk of 14.5% for total mortality to 41.5% for AF in those with subclinical hyperthyroidism. Risks for CHD mortality and AF (but not other outcomes) were higher for thyrotropin level lower than 0.10 mIU/L compared with thyrotropin level between 0.10 and 0.44 mIU/L (for both, P value for trend, ≤.03). Conclusion: Endogenous subclinical hyperthyroidism is associated with increased risks of total,CHDmortality, and incident AF, with highest risks of CHD mortality and AF when thyrotropin level is lower than 0.10 mIU/L.

Original languageEnglish
Pages (from-to)799-809
Number of pages11
JournalArchives of Internal Medicine
Issue number10
Publication statusPublished - May 28 2012

ASJC Scopus subject areas

  • Internal Medicine


Dive into the research topics of 'Subclinical hyperthyroidism and the risk of coronary heart disease and mortality'. Together they form a unique fingerprint.

Cite this